Georgiamune

Developer of immunotherapeutics to treat cancer and autoimmune diseases

placeGaithersburg, Maryland, United States calendar_todayFounded 2019 groups14 employees language georgiamune.com

Registered entities

Innovation

12 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 359 times.

YearFilings
20215
20225
202311
202412
20258
20264

Social engagement

Social engagement: 2.3K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include General Catalyst, PICI.

Investor typeCountShare
Venture capital338%
Private equity113%
Other / undisclosed450%

Recent activity

15 Jan 2026
Recognition
2 Dec 2025
Recognition
20 Nov 2025
Recognition
Coming soon